Ocuphire Pharma (OCUP)
(Real Time Quote from BATS)
$1.25 USD
-0.01 (-0.79%)
Updated Aug 30, 2024 01:52 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Ocuphire Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -9.99 | 17.89 | -56.69 | -24.62 | -8.64 |
Depreciation/Amortization & Depletion | 0.01 | 0.00 | 0.00 | 0.01 | -0.07 |
Net Change from Assets/Liabilities | 4.08 | -5.56 | 0.18 | 1.15 | 0.22 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.79 | 1.98 | 37.14 | 16.67 | -1.80 |
Net Cash From Operating Activities | -1.11 | 14.31 | -19.37 | -6.80 | -10.28 |
Property & Equipment | 0.00 | 0.00 | -0.10 | -1.48 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 3.11 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | -0.10 | 0.54 | 3.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 9.26 | 4.46 | 28.58 | 0.06 | 7.65 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 23.35 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | -0.54 | 0.54 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.28 | -0.13 | -1.51 | -2.29 | 0.00 |
Net Cash from Financing Activities | 8.98 | 3.79 | 27.61 | 21.12 | 7.65 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 7.87 | 18.10 | 8.14 | 14.86 | 0.48 |
Cash at Beginning of Period | 42.63 | 24.53 | 16.40 | 1.54 | 8.74 |
Cash at End of Period | 50.50 | 42.63 | 24.53 | 16.40 | 9.22 |
Diluted Net EPS | -0.46 | 0.87 | -3.82 | -5.28 | -8.72 |
Fiscal Year End for Ocuphire Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -14.87 | -7.11 | -9.99 | -5.19 | -10.75 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 0.06 | 0.40 | 4.08 | -4.58 | 5.84 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.80 | 1.00 | 4.79 | 4.10 | 2.25 |
Net Cash From Operating Activities | -13.01 | -5.72 | -1.11 | -5.66 | -2.66 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.00 | 2.44 | 9.26 | 5.38 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.08 | -0.06 | -0.28 | 0.00 | 0.00 |
Net Cash from Financing Activities | 3.92 | 2.38 | 8.98 | 5.38 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -9.09 | -3.34 | 7.87 | -0.28 | -2.66 |
Cash at Beginning of Period | 50.50 | 50.50 | 42.63 | 42.63 | 42.63 |
Cash at End of Period | 41.41 | 47.16 | 50.50 | 42.35 | 39.98 |
Diluted Net EPS | -0.30 | -0.29 | -0.19 | 0.25 | -0.24 |